Immunohistochemical Expression of COX2 in Urothelial Carcinoma of the urinary bladder
Background and objectives: Urothelial carcinoma of urinary bladder constitutes 90% of bladder cancer cases. Cyclo-oxygenase 2 as an immune-histochemical marker, is not expressed in normal tissues, while it is expressed in some cancers including urothelial carcinoma. The purpose of this study is det...
Saved in:
| Main Authors: | Shayan Khattab Omer, Jalal Ali Jalal, Zheen Othman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kurdistan Higher Council Of Medical Specialties
2024-12-01
|
| Series: | Advanced Medical Journal |
| Subjects: | |
| Online Access: | https://amj.khcms.edu.krd/index.php/main/article/view/520 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunohistochemical expression of GATA3 in urothelial carcinoma of urinary bladder
by: Shadan Abdulkhaliq Jaf, et al.
Published: (2024-12-01) -
Immunohistochemical Expression of Cyclooxygenase-2 in endometrioid carcinoma
by: Kavi Kamaran Abbas, et al.
Published: (2024-09-01) -
The Evaluation of CD10 and HER2 Immunohistochemical Markers in Urothelial Carcinoma of Urinary Bladder
by: Khalid W. Abdulfattah Khattab, et al.
Published: (2024-12-01) -
Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
by: Kira Furlano, et al.
Published: (2024-11-01) -
Microsatellite instability and mismatch repair deficiency in bladder urothelial carcinoma: a Tunisian single-center study
by: Ahlem Bdioui, et al.
Published: (2025-05-01)